NT-proBNP/cTnI Fast Test Kit
- UID
- IMP/IVD/2019/000403_f52eb97bb8fcff80864707e87d6d5129_1a17034a4b6c5321a93bf0f24fd4b9c8
- Device class
- Class C
- Brand name
- Imumunofluorescence Assay
- License holder
- M/s. Reckon Diagnostics Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- NT-proBNP/cTnl Fast Test Ktt (Imumunofluorescence Assay) is intended for in vitro quantitative determination of N-terminal B- type natriuretic peptide precursor/cardiac Troponin I (Imumunofluorescence Assay) in serum, plasma or whole blood. This test is used as an aid in the clinical diagnosis, prognosis and evaluation of Heart Failure (Imumunofluorescence Assay), Acute Myocardial Infarction (Imumunofluorescence Assay) and Acute Coronary Syndrome (Imumunofluorescence Assay)
NT-proBNP/cTnI Fast Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000403_f52eb97bb8fcff80864707e87d6d5129_1a17034a4b6c5321a93bf0f24fd4b9c8. This device is marketed under the brand name Imumunofluorescence Assay. The license holder is M/s. Reckon Diagnostics Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.